You are here

Development of a porcine model of polycystic kidney disease by multiplex gene-editing.

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R43DK104500-01
Agency Tracking Number: R43DK104500
Amount: $352,419.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: NIDDK
Solicitation Number: PA13-092
Timeline
Solicitation Year: 2014
Award Year: 2014
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
1246 University Ave W
SAINT PAUL, MN 55104-4125
United States
DUNS: 829874523
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 DANIEL CARLSON
 (612) 727-2000
 dan@recombinetics.com
Business Contact
 DANIEL CARLSON
Phone: (612) 727-2000
Email: dan@recombinetics.com
Research Institution
 Stub
Abstract

? DESCRIPTION (provided by applicant): Polycystic kidney diseases (PKD) are a group of inherited disorders characterized by progressive cyst development in the kidney resulting in bilateral renal enlargement and often end stage renal disease (ESRD). The most common form of PKD, autosomal dominant PKD occurs at a frequency of 1:400 to 1:1000. Currently, there is no treatment that can slow or reverse the growth of cysts and progression of the disease. While mouse models have been developed to characterizethe pathology and progression of PKD, they tend to be poor indicators of therapeutic success in humans. We propose to develop two specific knock-in models of PKD, closely matching the genetic changes observed in human disease development. These pig modelswill be developed using Recombinetics exclusive license for gene-editing in livestock using TALEN technology. The resulting pigs will be evaluated for renal morphology, function, and the development of cysts, and compared to the pathology and development

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government